Medicine & Health

Researchers at the School of Medicine have identified a novel enzyme involved in building the cell wall of Cryptococcus neoformans, a fungus that causes lung infections and potentially deadly cases of meningitis, primarily in people with AIDS.

Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.

A team from Washington University School of Medicine in St. Louis and Saint Louis University have established the Midwest Developmental Center for AIDS Research to help end the HIV epidemic in the region.

Washington University School of Medicine in St. Louis has formed a Center for Translational Bioinformatics. The center aims to accelerate research that can improve patient care by integrating comprehensive patient data and expansive genomic datasets.

Researchers at Washington University can more effectively study mutations that cause heart disease by putting stem cells through their paces. Their research offers insight into the origins of hypertrophic cardiomyopathy.

A study by researchers at Washington University School of Medicine in St. Louis shows that people with COVID-19 who used cannabis were more likely to be hospitalized and require intensive care than those who did not use the drug.

Researchers at Washington University School of Medicine in St. Louis have found that safety interventions — such as walkers, grab bars, ramps and other home modifications — allow many stroke survivors to keep living independently in their homes and may reduce their risk of death.

In a new study, a team of researchers at Washington University School of Medicine in St. Louis reports that a drug approved by the FDA for another condition may stabilize vision for patients with RVCL-S, a rare genetic disease.

New research from Washington University School of Medicine in St. Louis may help offer treatment options for pregnant people with substance use disorders. The study indicates that patients with opioid use disorders and ADHD who remain on ADHD medications during pregnancy are far more likely to adhere to treatment, and far less likely to overdose.

Adam Wilcox, a professor of medicine at Washington University School of Medicine in St. Louis, has been named the chair of the Patient-Centered Outcomes Research Institute Methodology Committee.